HCID 53876405, 화합물 → HCID 500951, 화합물
반응식
C(OC(=O)[N:7]([CH2:15][CH2:16][CH2:17][O:18][C:19]1[C:24]2[C:25]([CH3:36])=[C:26]([CH:28]([OH:35])[C:29]3[CH:34]=[CH:33][CH:32]=[CH:31][N:30]=3)[O:27][C:23]=2[CH:22]=[CH:21][CH:20]=1)[CH2:8][C:9]1[CH:10]=[N:11][CH:12]=[CH:13][CH:14]=1)(C)(C)C>C(Cl)(Cl)Cl.[O-2].[Mn+4].[O-2]>[CH3:36][C:25]1[C:24]2[C:19]([O:18][CH2:17][CH2:16][CH2:15][NH:7][CH2:8][C:9]3[CH:10]=[N:11][CH:12]=[CH:13][CH:14]=3)=[CH:20][CH:21]=[CH:22][C:23]=2[O:27][C:26]=1[C:28]([C:29]1[CH:34]=[CH:33][CH:32]=[CH:31][N:30]=1)=[O:35]참가 물질
4
실험 절차
To a solution of {3-[2-(hydroxy-pyridin-2-yl-methyl)-3-methyl-benzofuran-4-yloxy]-propyl}-pyridin-3-ylmethyl-carbamic acid tert-butyl ester (30 mg) in chloroform (2 ml) was added manganese(IV) oxide (45 mg) at room temperature and the mixture was stirred vigorously overnight. The mixture was filtered through a pad of Celite and concentrated in vacuo. The titled compound (24 mg) was obtained as a pale yellow oil after the purification with silica gel TLC developed by the mixture of dichlormethane and methanol. FAB-MS: m/z 502 (MH+); 1H-NMR (CDCl3): δ 1.45 (9H, s), 2.10-2.15 (2H, m), 2.91 (3H, s), 3.40-3.50 (2H, m), 4.09 (2H, t, J=5.9 Hz), 4.48 (2H, broad s), 6.58 (1H, d, J=8.3 Hz), 7.10 (1H, d, J=8.3 Hz), 7.24 (1H, dd, J=5.3 Hz, 7.6 Hz), 7.34 (1H, t, J=8.3 Hz), 7.47-7.55 (2H, m), 7.87-7.98 (2H, m), 8.50-8.53 (2H, m), 8.77-8.80 (1H, m).